D2033Nレジスタンス変異を有するROS1再編成NSCLCにおけるレポトレチニブ有効性の最初の臨床証拠:症例報告
Yukiko Yoshida1, Hiroshi Yokouchi2, Hidenori Mizugaki1
1Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Japan.
Clinical lung cancer
|September 3, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.5K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K
